Evidence map›Paper›PMID 30719250›Full record

ArticleBasic and clinical neuroscience

Chemical Composition and Role of Opioidergic System in Antinociceptive Effect of

Faezeh Mohammadifard, Samad Alimohammadi

Open access · diamondAbstract read
In one paragraph

Article in Basic and clinical neuroscience. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.9field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 17 citations in OpenAlex.

  1. Anti-inflammatory and antinociceptive effects ofJournal of traditional and complementary medicine · 2025
    Article
  2. Article
  3. Article
  4. Article
  5. Assessment of antinociceptive property ofThe Korean journal of pain · 2024
    Article
  6. Article
  7. Evaluation ofFrontiers in chemistry · 2024
    Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Faezeh MohammadifardDepartment of Basic Sciences, Faculty of Veterinary Medicine, Razi University, Kermanshah, Iran.ORCID https://orcid.org/0000-0002-9000-2530
Samad AlimohammadiDepartment of Basic Sciences, Faculty of Veterinary Medicine, Razi University, Kermanshah, Iran.ORCID https://orcid.org/0000-0001-7489-4578
Razi University · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introduction

methodsSixty-four male Wistar rats were divided into eight groups. The groups 1 to 7 were injected with normal saline, vehicle (Tween-80, 0.5%), 10, 20, 40 mg/kg of the EOZC, morphine (5 mg/kg) and naloxone (2 mg/kg), respectively. Thirty minutes later, the formalin test was performed by intraplantar injection of formalin (50 μL, 2%). In group 8, naloxone (2 mg/kg) was injected 15 min before injection of EOZC (20 mg/kg), followed by formalin at 15 min later. The formalin test was done as time spent for licking and biting of the injected paw. Formalin induced a biphasic pain reaction. The chemical composition of EOZC was identified using Gas Chromatography-Mass Spectrometry (GC-MS).

resultsEOZC (10, 20, and 40 mg/kg) dose dependently and morphine (5 mg/kg) reduced pain responses in the both phases of pain (P<0.05). Naloxone (2 mg/kg) alone had no effect on the severity of pain (P>0.05) but pretreatment with naloxone inhibited EOZC-induced antinociception activity (P<0.05). Based on the GC-MS results, EOZC comprised 65.22% carvacrol, 19.51% thymol, 4.86% p-cymene and 4.63% γ-terpinene.

conclusionThese results demonstrate that EOZC has antinociceptive effect and this effect might mediate via opioidergic pathways.

Indexed as

AntinociceptiveOpioidergicRatZiziphora Clinopodioides

Identifiers

PMID30719250
PMCPMC6360493
OpenAlexW2901856843

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.